Minnie Sarwal, M.D., F.R.C.P., D.C.H., Ph.D.
Stanford University, California, USA
Minnie Sarwal is Professor of Pediatrics and Immunology and Medical Director of the Pediatric RenalTransplantation Program at Stanford University, California, USA. She graduated from Calcutta Medical College, India and Guy’s Hospital, London, UK, before completing a doctorate in Molecular Genetics at Cambridge University, Cambridge, UK with Nobel Laureate Sydney Brenner.
Professor Sarwal is a member of several national and international societies. She has served on many Committees for the American Transplant Congress, International Pediatric Transplant Association, the American Society of Nephrology and the National Institutes of Health and is a Councilor for the IPTA.
A prolific speaker, Professor Sarwal has presented at numerous national and international meetings and chaired several sessions. Her career has been marked by a number of awards and distinctions, including the Order of Excellence in Scientific Research (Cambridge, UK, 2002) and the Dean’s Teaching Award (2005) as well as the Junior Faculty Award from the CCIS (2003-6). In addition, she has been listed in Best Doctors in California and WHO’s WHO in Medicine. She was also cited several times as a Key Opinion Leader in Organ Transplantation by the Transplantation Society (2007-2009) and is an elected Senator at Large for the Stanford Faculty Senate. In 2010, she was awarded the TTS-Roche Award for Outstanding Achievement Transplantation Science (Clinical), an international award only given every two years.
Professor Sarwal has served as an Associate Editor of American Journal of Transplantation and has previously acted as peer reviewer for publications such as Lancet, Nature Medicine, NEJM, Transplantation and Kidney International. In addition she has also authored and co-authored more than 150 publications, including textbook chapters and papers published in peer-reviewed journals.
Professor Sarwal’s research interests are truly translational, and are centered on the immunological basis of graft dysfunction and acceptance, using genomic and proteomic approaches, as well as immunosuppression clinical trial designs. She directs her basic science lab (http://www.sarwal.stanford.edu) at Stanford University and has pioneered numerous multicentre clinical trials in this field, including the first NIH funded randomized trial on steroid avoidance and Genentech funded rituximab trial for acute rejection in pediatric renal transplantation.